Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000710091 | SCV000255647 | pathogenic | not provided | 2015-07-28 | criteria provided, single submitter | clinical testing | Not found in the total gnomAD dataset, and the data is high quality. Assessment of experimental evidence suggests this variant results in abnormal protein function. Segregation with disease in affected individuals from a single family. |
Eurofins Ntd Llc |
RCV000710091 | SCV000333339 | uncertain significance | not provided | 2016-12-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000201159 | SCV000645464 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 373 of the CAPN3 protein (p.Trp373Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal recessive limb-girdle muscular dystrophy (PMID: 18337726, 30564623; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 217145). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects CAPN3 function (PMID: 18258189). For these reasons, this variant has been classified as Pathogenic. |
Counsyl | RCV000201159 | SCV000800735 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2017-10-10 | criteria provided, single submitter | clinical testing | |
Clinical Genetics and Genomics, |
RCV000710091 | SCV001450290 | likely pathogenic | not provided | 2015-10-29 | criteria provided, single submitter | clinical testing | |
Kariminejad - |
RCV001814104 | SCV001755642 | likely pathogenic | Abnormality of the musculature | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710091 | SCV002520218 | likely pathogenic | not provided | 2022-05-23 | criteria provided, single submitter | clinical testing | Individual homozygous for the W373R variant was found to have absent CAPN3 protein on western blot (Duno et al., 2008); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 18258189, 16627476, 33281875, 22443334, 18337726, 30564623, 32528171, 27535533, 33726816) |
MGZ Medical Genetics Center | RCV000201159 | SCV002581630 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2022-07-28 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000710091 | SCV003822477 | likely pathogenic | not provided | 2022-02-07 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV000201159 | SCV004014008 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-02-10 | criteria provided, single submitter | clinical testing | PM2, PP2, PP3, PP5 |
Institute of Human Genetics Munich, |
RCV000201159 | SCV004045895 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-07-04 | criteria provided, single submitter | clinical testing | |
Center of Genomic medicine, |
RCV000201159 | SCV004100670 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-03-10 | criteria provided, single submitter | clinical testing | This variant was identified in an homozygous state in a patient with limb-girdle muscular dystrophy |
Ce |
RCV000710091 | SCV004136422 | uncertain significance | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | CAPN3: PM2, PM3 |
Baylor Genetics | RCV003462345 | SCV004213777 | likely pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000201159 | SCV004809356 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000710091 | SCV001740459 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000710091 | SCV001800018 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |